Croatian longevity startup GlycanAge secures €3.9 million to advance personalized preventative care
GlycanAge, a biotech startup pioneering the field of glycan biomarkers, announced the successful completion of its €3.9 million seed funding round, led by LAUNCHub Ventures and UK-based deep-tech fund Kadmos Capital.
Read the article on EU Startups >
Read More from the Global Wellness News ™